Acquisition of Hema Diagnostics Systems, LLC (Tables)

12 Months Ended

Jul. 31, 2018

Business Combinations [Abstract]

Net purchase price of HDS

	Stock Price at Closing		Shares		Fair Value
Purchase price:
Common Stock at closing	$	4.77		53,191	$	253,721
Common Stock after closing	$	4.77		20		95
Common Stock post reverse stock split	$	4.77		230,000		1,097,100
Total purchase price					$	1,350,916

Fair Value Assumptions Used in Accounting for Warrants

	July 31, 2018			July 31, 2017
Exercise price		2.50			2.50
Time to expiration		3.47 years			4.47 years
Risk-free interest rate		2.77	%		1.84	%
Estimated volatility		143.97	%		122.7	%
Dividend		—			—
Stock price at valuation date	$	2.05		$	5.05

Fair Value Assumptions Used in Accounting for Call Options

	July 31, 2018			July 31, 2017
Risk-free interest rate		2.44	%		1.34	%
Estimated volatility		129.95	%		143.9	%
Remaining Term		1.47			2.47
Stock price at valuation date	$	2.05		$	5.05

Purchase price allocation of HDS

Cash and cash equivalents		$	12,363
Accounts receivable, net			980
Inventory, net			21,141
Other current assets			91,474
Property and equipment, net			4,249
Other assets, net			39,675
Accounts payable and accrued expenses			(489,390	)
Loan to related parties			(13,323,391	)
Net assets of HDS			(13,642,899	)
Non-controlling interest			(1,297,939	)
In-Process Research & Development			2,911,377
Goodwill			13,380,377
Total Purchase Price	51% Ownership	$	1,350,916